Altomed Malhotra Platinum Segments
510(k) K170591
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK170591 | Date6 Jun 2017 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- MML
- Device Class
- Class II
- Regulation
- 21 CFR Part 886.5700
- Advisory Committee
- Ophthalmic
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 26 Sep 2026
The Malhotra Platinum Segments are eyelid weights designed to provide gravity-assisted treatment for lagophthalmos. These devices are sutured in a flexible chain format that molds to the contour of the patient's eye.
The Malhotra Platinum Segments are available in 0.2g and 0.4g sizes and should not be used on patients with known allergies to platinum, iridium or nickel. The device is FDA 510(k) cleared with product code MML and is classified as an ophthalmic device.
Questions
AI-generated answers, 26 Sep 2026
What are the Altomed Malhotra Platinum Segments used for?
The Malhotra Platinum Segments are eyelid weights designed to provide gravity-assisted treatment for lagophthalmos. They are sutured in a flexible chain format that molds to the contour of the patient's eye.
What sizes are available for the Malhotra Platinum Segments?
The Malhotra Platinum Segments are available in two sizes: 0.2g and 0.4g. These different weight options allow for customized treatment based on the patient's specific needs and the severity of their condition.
Are there any contraindications for using the Malhotra Platinum Segments?
The device should not be used on patients with known allergies to platinum, iridium or nickel. These materials are part of the device composition, and allergic reactions could occur in sensitive individuals.
What is the regulatory status of the Malhotra Platinum Segments?
The device is FDA 510(k) cleared with product code MML and is classified as an ophthalmic device. It received clearance through the traditional pathway with a decision code of SESE (Substantially Equivalent) on June 6, 2017.